DarioHealth Corp. (DRIO) Latest Company News

Aug 21, 2026, 00:00 UTC
DarioHealth Corp. appointed Steven Nelson as Independent Consultant, effective October 1, 2026, with a grant of 30,000 shares of restricted common stock vesting on the first anniversary or upon a Change in Control.
Aug 21, 2026, 00:00 UTC
DarioHealth Corp. terminated Steven Nelson as President and Chief Commercial Officer, effective September 1, 2026, with severance including accrued wages, health insurance through September 30, 2026, and up to three months of COBRA reimbursement.
Aug 11, 2026, 10:30 UTC
DarioHealth reported second quarter 2026 financial results with revenue of $5.2 million, gross margin of 62%, and a 30% year-over-year decrease in operating loss.
Source:
Aug 4, 2026, 11:30 UTC
DarioHealth Corp. launched Dario Women and Dario Sleep, two new AI-enabled programs expanding its provider-backed cardiometabolic platform into women's health and sleep solutions, with revenue contribution expected to begin in Q4 2026.
Source:
- prnewswire.com
Jul 16, 2026, 11:30 UTC
DarioHealth Corp. announced that a Fortune 50 employer has awarded it a contract to deliver its AI-powered cardiometabolic care platform to over 100,000 eligible employees.
Source:
- prnewswire.com
Jul 6, 2026, 11:30 UTC
DarioHealth Corp. announced a new agreement with a major health insurer in Arizona, entered through its partnership with Amwell, to provide its cardiometabolic digital health solution to the insurer's ASO book of business covering hundreds of thousands of lives.
Source:
- prnewswire.com
Jun 29, 2026, 11:00 UTC
DarioHealth entered into a Collaborative Services Agreement with Beluga Health to deliver a provider-backed, digitally-enabled model for longitudinal care.
Source:
- prnewswire.com

DRIO

DarioHealth Corp. appointed Steven Nelson as Independent Consultant, effective October 1, 2026, with a grant of 30,000 shares of restricted common stock vesting on the first anniversary or upon a Change in Control.

DarioHealth Corp. terminated Steven Nelson as President and Chief Commercial Officer, effective September 1, 2026, with severance including accrued wages, health insurance through September 30, 2026, and up to three months of COBRA reimbursement.

DarioHealth reported second quarter 2026 financial results with revenue of $5.2 million, gross margin of 62%, and a 30% year-over-year decrease in operating loss.

DarioHealth Corp. launched Dario Women and Dario Sleep, two new AI-enabled programs expanding its provider-backed cardiometabolic platform into women's health and sleep solutions, with revenue contribution expected to begin in Q4 2026.

DarioHealth Corp. announced that a Fortune 50 employer has awarded it a contract to deliver its AI-powered cardiometabolic care platform to over 100,000 eligible employees.

DarioHealth Corp. announced a new agreement with a major health insurer in Arizona, entered through its partnership with Amwell, to provide its cardiometabolic digital health solution to the insurer's ASO book of business covering hundreds of thousands of lives.

DarioHealth entered into a Collaborative Services Agreement with Beluga Health to deliver a provider-backed, digitally-enabled model for longitudinal care.